Applying Machine Learning Techniques to Predict Drug-Related Side Effect: A Policy Brief.

Area of Science:

• Pharmacovigilance
• Health Informatics
• Regulatory Science

Background:

• Traditional drug safety monitoring may not detect rare or long-term side effects.
• Machine learning (ML) shows potential for early prediction of drug-related adverse events.

Purpose of the Study:

• To propose evidence-based policy options for utilizing ML in predicting drug-related side effects.
• To address barriers and opportunities in ML adoption for drug safety.

Main Methods:

• Scoping review of relevant studies.
• Secondary analysis of barriers and opportunities for policy development.
• Synthesis of policy recommendations.

Main Results:

• Challenges identified include data standardization, model interpretability, and regulatory alignment.
• Explainable ML and cross-sector collaboration can enhance prediction accuracy and fairness.
• Five policy recommendations were proposed for data collection, model validation, integration, public awareness, and fairness regulations.

Conclusions:

• ML offers significant potential for advancing drug safety and patient outcomes.
• Ethical, regulatory, and technical challenges must be addressed for effective ML implementation.
• Interdisciplinary coordination and evidence-based policymaking are crucial for responsible ML adoption in drug development.